129 related articles for article (PubMed ID: 35113348)
1. Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic.
Sakamoto K; Ono R; Doi T; Koga Y; Shioda Y;
Int J Hematol; 2022 Mar; 115(3):446-448. PubMed ID: 35113348
[No Abstract] [Full Text] [Related]
2. Secondary HLH is uncommon in severe COVID-19.
Wood H; Jones JR; Hui K; Mare T; Pirani T; Galloway J; Metaxa V; Benjamin R; Rutherford A; Cain S; Kulasekararaj AG
Br J Haematol; 2020 Sep; 190(5):e283-e285. PubMed ID: 32526046
[No Abstract] [Full Text] [Related]
3. A histopathological observation regarding the possibility of hemophagocytic lymphohistiocytosis in COVID-19 patients.
Abdollahi A; Beigmohammadi MT; Safaei M; Mehrtash V; Jafarzadeh B
J Gastrointestin Liver Dis; 2020 Sep; 29(3):475-476. PubMed ID: 32919429
[No Abstract] [Full Text] [Related]
4. Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.
Sprute R; Hieber ML; Jachimowicz RD
Infection; 2022 Dec; 50(6):1617-1618. PubMed ID: 35389184
[No Abstract] [Full Text] [Related]
5. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.
Dewaele K; Claeys R
Blood; 2020 Jun; 135(25):2323. PubMed ID: 32556137
[No Abstract] [Full Text] [Related]
7. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression.
Lubnow M; Schmidt B; Fleck M; Salzberger B; Müller T; Peschel G; Schneckenpointner R; Lange T; Hitzenbichler F; Kieninger M; Lunz D; Graf B; Brochhausen C; Weber F; Lüke F; Peterhoff D; Schuster P; Hiergeist A; Offner R; Hehr U; Wallner S; Hanses F; Schmid S; Weigand K; Geismann F; Poeck H; Pukrop T; Evert M; Gessner A; Burkhardt R; Herr W; Maier LS; Heudobler D
Int J Infect Dis; 2021 Feb; 103():624-627. PubMed ID: 33412272
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
10. Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19.
Hueso T; Bouchez C; Salviat F; Foulon S; Albiges L; Bayle A; Gallois E; Vergé V; Boige V; Griscelli F; Pommeret F; Ghez D
Br J Haematol; 2021 Feb; 192(3):e87-e90. PubMed ID: 33326597
[No Abstract] [Full Text] [Related]
11. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
12. Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-2.
Alhumaidan W; Al-Otaibi A; Elyamany G; Alabbas F; Ali TB
Pediatr Hematol Oncol; 2021 May; 38(4):406-409. PubMed ID: 33635161
[No Abstract] [Full Text] [Related]
13. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
14. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
Loscocco GG; Malandrino D; Barchiesi S; Berni A; Poggesi L; Guglielmelli P; Vannucchi AM
Int J Lab Hematol; 2020 Dec; 42(6):e270-e273. PubMed ID: 32776691
[No Abstract] [Full Text] [Related]
15. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.
Feld J; Tremblay D; Thibaud S; Kessler A; Naymagon L
Int J Lab Hematol; 2020 Dec; 42(6):773-779. PubMed ID: 32790918
[TBL] [Abstract][Full Text] [Related]
16. Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic.
Harama D; Goi K; Saito K; Sato H; Somazu S; Furuichi Y; Takahashi K; Oshiro H; Nakamura M; Sawanobori E; Sato K; Tsuruta M; Murakami Y; Shinohara T; Nemoto A; Kasai S; Tamai M; Watanabe A; Akahane K; Kojika S; Sugita K; Inukai T
Int J Hematol; 2023 Feb; 117(2):307-308. PubMed ID: 36633776
[No Abstract] [Full Text] [Related]
17. Haemophagocytic lymphohistiocytosis in COVID-19 cases?
Tveiten H; Aukrust P; Lehne G; Rodriguez JR; Skjønsberg OH
Tidsskr Nor Laegeforen; 2020 Apr; 140(6):. PubMed ID: 32321221
[No Abstract] [Full Text] [Related]
18. Familial Hemophagocytic Lymphohistiocytosis.
Degar B
Hematol Oncol Clin North Am; 2015 Oct; 29(5):903-13. PubMed ID: 26461150
[TBL] [Abstract][Full Text] [Related]
19. Consider Hemophagocytic Lymphohistiocytosis as a New Cause of Death in COVID-19 With Presentation of Acute Liver Failure: A Case Report.
Ataollahi M; Haghshenas H; Karbasian F; Darban B; Haghighat M
Pediatr Infect Dis J; 2022 Apr; 41(4):e186. PubMed ID: 35185143
[No Abstract] [Full Text] [Related]
20. Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
Takami A
Int J Hematol; 2020 Jul; 112(1):127. PubMed ID: 32468178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
